New Delhi, 29 January (PTI) Temasake Holdings and TPG-supported Dr. The initial public offer of Aggarwal’s Health Care Limited, an eye care services provider, received 7 percent membership on the first day of bidding on Wednesday.
Public issue received bids for 38,08,980 shares against 5,35,26,172 shares on the proposal as per NSE data.
Part for retail individual investors (RII) received 11 percent membership, while the category for non-institutional investors received 6 percent membership.
On Tuesday, Dr. Aggarwal’s health care said it is over 875.5 crores from anchor investors.
3,027.26-Garrow public issue, with price band On 382 402 per share will end on 31 January.
IPO is a combination of a new issue above A proposal for sale for 300 crore and 6.78 crore equity shares (O.S) 2,727.26 crore by promoters and other sales shareholders at the upper end of the price band.
Arvon Investments PTE LTD, Clamore Investments (Mauritius) PTE LTD, and Hyperion Investments PTE Ltd.
From latest issue to tune 195 crores will be used for payment of loan. In addition, a portion will be used for general corporate purposes and unknown inorganic acquisitions.
Dr. Aggarwal offers a wide range of health care services, including cataract, refractory, and other surgery, counseling, diagnosis, non-surgical remedies, and optical products, contact lenses, goods and eye care related drugs. Is.
By September 2024, its network included 193 features with majority concentrations in South India, especially Chennai, Hyderabad and Bengaluru, followed by Western India.
Kotak Mahindra Capital Company, Morgan Stanley India Company, Jefferies India and Motilal Oswal are the book-hanging lead manager for the Investment Advisor.
